MedTrace Logo

Prevalence Of Disability And Fear Avoidance Beliefs

NCT07286630 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 381

Last updated 2026-03-13

No results posted yet for this study

Summary

Three hundred eighty -one egyptian physical therapists of both genders with age 25-55 years old in Cairo governorate who have worked for at least two years.The study will be conducted to investigate the prevalence of disability and fear avoidance beliefs among egyptian physical therapists with chronic non-specific low back pain (CNSLBP), and data will be collected through self-administered questionnaires distributed electronically.Participants were recruited from various public and private physical therapy centers and hospitals in Cairo .

Conditions

  • Chronic Non-specific Low Back Pain

Interventions

OTHER

Fear avoidance beliefs questionnaire

* Fear avoidance beliefs will be measured using the FABQ. It contains 16 items, scored from 0-6 (completely agree to completely disagree). It consists of two subscales, the physical activity subscale (FABQ PA), scored out of 24 (scores of ≤15 indicate low and \>15 indicate high fear avoidance), and work (FABQ W), scored out of 42 points (scores of ≤34 indicate low and \>34 indicate high fear avoidance) * Oswestrydisability examines the level of disability in 10 everyday activities of daily living. * Pain intensity -Personal care -Lifting * Walking -Sitting -Standing * Sleeping -Sex (if applicable) * Social -Travel (Physiopedia, n.d.). * Each component is assigned a value between 0 and 5, with 5 indicating the most disability. The index is calculated by dividing the total score by the range of scores and multiplying the result by 100 to get the index's percentage value .

Sponsors & Collaborators

  • Dina Abdelhady Hammad Attia Ahmed

    lead OTHER

Principal Investigators

  • Dina Abdelhady Hammad, Bachaleor · Cairo University

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-07
Primary Completion
2025-11-20
Completion
2026-05-13

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07286630 on ClinicalTrials.gov